Introduction
The overexpression of the c-neu/erbB2 protein represents one of the most frequent genetic alterations of human breast cancer (for review, see Salomon et al., 1995) and correlate with a more aggressive breast cancer phenotype (Slamon et al., 1987) . The c-neu/erbB2 gene is a member of the erbB family of receptor tyrosine kinases (Salomon et al., 1995) . It codes for a 185 kDa transmembrane (TM) protein (Padhy et al., 1982) . Mutation-induced transforming alleles of the c-neu/erbB2 proto-oncogene have been shown to harbor a single point mutation in the TM domain of the protein (Bargmann et al., 1986) , leading to the constitutive activation of its tyrosine kinase (Bargmann and Weinberg, 1988) .
In mice, studies of experimental mammary cancers have been carried out largely on tumors induced by a retrovirus, the murine mammary tumor virus (MMTV) (for review, see Moore et al., 1979) . In these tumors, the MMTV provirus has been found to activate several genes by insertional mutagenesis: wnt-1/int-1, Fgf-3/int-2, Fgf-4/hst-1, wnt-3/int-4, Notch4/int-3, Fgf-8/AIGF, int-6, wnt-10b, int-H, int-P, int41 and Tpl-2/cot (Rosenberg and Jolicoeur, 1997; Callahan, 1996) . Some of these genes (wnt-1/int-1, wnt-3/int-4 and wnt10b) are members of the Wnt gene family (for review, see Nusse and Varmus, 1992) .
More recently, models of mammary tumors have also been developed by overexpressing various protooncogenes or activated oncogenes in transgenic (Tg) mice (Webster and Muller, 1994) . We have previously reported that, in one of these Tg mouse models (MMTV/neu) expressing the activated c-neu/erbB2 gene, mammary tumors developed stochastically after a relatively long latent period, suggesting that the activated c-neu/erbB2 oncogene was not sucient to fully transform mammary epithelial cells and that other genetic events were required for this phenotype (Bouchard et al., 1989) .
To identify these additional genetic events, we used the provirus insertional mutagenesis approach with tumors arising in MMTV-infected MMTV/neu Tg mice. We found that in some tumors, the Notch1 gene has been targeted and truncated by the MMTV provirus. Notch1 is the mammalian homologue of the Drosophila Notch gene and encodes a large 330 kDa TM protein. It has been shown to control cell-fate determination in several tissues (for review, see Artavanis-Tsakonas et al., 1995) . The extracellular domain of Notch1 harbors 36 EGF-repeats, three Notch-Lin12 repeats and two conserved cysteines (C 1652 and C
1685
) close to the TM domain. The intracellular Notch1 domain contains six CDC10/ ankyrin repeats and OPA and PEST sequences at the C-terminus. We report here that a truncation of the Notch1 gene by the MMTV provirus occurred in a region just upstream of the exons coding for the TM domain and resulted in the activation of the remaining truncated intracellular Notch1 domain. We also present evidence that an activated Notch1 intra cDNA can transform mouse HC11 mammary epithelial cells in vitro.
Results

Notch1 is mutated by MMTV provirus in mammary tumors of MMTV-infected MMTV/neu Tg mice
To determine whether Notch1 was mutated in mammary tumors of MMTV-infected MMTV/neu Tg mice, we searched for rearrangement of the Notch1 gene, using the Southern technique with tumor DNAs hybridized with Notch1 genomic probe D and cDNA probe J (Figure 1) . A novel tumorspeci®c fragment, in addition to the normal germline fragment, was detected in two out of 24 (8%) tumors screened (Figure 1a ). Other loci previously identi®ed as targets of MMTV provirus insertions in MMTV-induced mammary carcinoma (int-1/wnt-1, int-2/Fgf-3, Fgf-4/hst-1, wnt-3/int-4 and Notch-4/int-3) were also studied. Among the 24 tumors screened, only Wnt-1/int-1 was found to be rearranged at a low frequency (four out of 24) and these four Wnt-1 rearranged tumors did not show insertional activation of the Notch1 gene (data not shown). Restriction analysis with MMTV LTR and Notch1-speci®c probes showed that the novel rearranged Notch1 fragment harbored MMTV LTR sequences (Figure 1b and c), indicating that the rearrangement occurred as a consequence of MMTV provirus integration. In addition, restriction analysis performed with MMTV LTR, MMTV env and Notch1 speci®c probes and PCR-ampli®cation were used to map the site of insertion within Notch1 precisely and to determine the orientation of the proviruses in the two rearranged tumors (T1571-63 and T24c) (data not shown).
The structural organization of the inserted MMTV proviruses within Notch1 is schematically shown in Figure 1d . Interestingly, the MMTV proviruses have integrated between the genomic sequences coding for the last Notch/lin-12 repeats and the TM domain of the Notch1 gene.
Notch1 RNA expression phenotype in mammary tumors arising in MMTV-infected MMTV/neu Tg mice The RNA expression in mammary tumors harboring, or not, a Notch1 rearrangement was assessed by the Northern blotting procedure using Notch1 probe D or K (Figure 1d ). Both probes detected an 8/10 kb full-length RNA species present at dierent levels in several tumors (Figure 2a ). In both rearranged tumors a shorter novel RNA species (7 kb) was detected with probe D, but not with probe K (Figure 2a) , and its length corresponded to the distance between the 5' end RNA and the site of provirus integration (Figure 1d ). Higher levels of other novel truncated RNA species (3.5 and 4.5 kb), not observed in tumors with no rearrangement in Notch1, were detected with probe K in the T24c tumor exhibiting Notch1 rearrangement (Figure 2b ). In tumor 1571-63, at least one of these novel RNA species (3.5 kb) could be detected, although its levels were much lower than in tumor T24c. These truncated RNAs harbored almost exclusively intracellular sequences and are likely to be initiated from the MMTV LTR or endogenous cryptic promoter(s) (Figure 1d ). The pattern of expression of Notch1 proteins in the same tumors was studied with three dierent polyclonal antibodies (Ab) raised against the intracellular CDC10/Ankyrin repeats (Ab-intra1), against the OPA region (Ab-intra2) and against the extracellular Notch/lin-12 repeats (Ab-extra1) (Figure 1d ). Abextra1 detected two proteins of 330 and 280 kDa in most tumors analysed, the 280 kDa species being most abundant ( Figure 3a) . The highest levels of the 280 kDa protein species were found in the two tumors exhibiting Notch1 rearrangement (Figure 3a , lanes 3 and 13). The 280 kDa protein species was not detected with Ab-intra1 or Ab-intra2 indicating they harbor almost exclusively the ectodomain (Figure 1d ). Other work in our laboratory with very similar MuLV provirus insertions in Notch1 has shown that the 280 kDa species represent a mixture of normally processed Notch1 ectodomain, N(EC) WT , and of mutated truncated ectodomain, N(EC) Mut , encoded by the 7kb truncated Notch1 RNA (Hoemann et al., 1999) . The Ab-intra2 detected a number of truncated Notch1-related proteins of heterogeneous size (86 ± 110 kDa) in all tumors ( Figure 3b ). In both rearranged tumors expressing novel 3.5 ± 4.5 truncated Notch1 3' transcripts, higher levels of two species of *95 and/or 100 kDa proteins could be detected ( Figure 3b , lanes 3 and 13). These truncated proteins were not detected at such high levels in any of the tumors exhibiting no Notch1 rearrangement. These truncated proteins were not detectable with Ab-extra-1, indicating that they contained almost exclusively the intracellular domain (Notch1 intra ) ( Figure 1d ). These truncated 86 ± 110 kDa proteins could represent a pool to which both mutant truncated transcripts and fulllength processed proteins contribute (Girard et al., 1996) .
N-terminally truncated Notch1 can transform mammary epithelial cells in vitro
To determine whether the truncated Notch1 gene generated by provirus insertion had some transformation potential in vitro, a N-terminally truncated Notch1 intra cDNA corresponding almost exactly to the truncated RNA expressed in MMTV-or MuLVinduced Notch1 rearranged tumors was inserted into the pcDNA3 and the retrovirus pBabe vectors. Infectious retrovirus stocks were generated with the pBabe/Notch1 retrovirus vector. Rat-1 ®broblasts and HC11 mammary epithelial cells were used for these assays.
Transfection of HC11 cells with the pcDNA3/ Notch1 construct gave rise to neomycin resistant cells which expressed only low levels of Notch1 RNA (data not shown). These cells did not form colonies in agar.
In contrast, infection of HC11 cells with the pBabe/ Notch1 retrovirus induced puromycin resistant cells which had a transformed morphology ( Figure 4b ) and were able to form colonies in soft agar (Figure 4d and e), although this virus was unable to transform Rat-1 ®broblasts (data not shown). Colony formation seemed to be proportional to the levels of Notch1 transcripts in each clone of HC11 cells analysed ( Figure 4f ). Since the provirus insertional mutations of Notch1 were found in Tg mice overexpressing another activated oncogene, neu/erbB2, we tested whether these two genes could collaborate for transformation of cells in vitro. HC11 cells and rat-1 ®broblasts expressing control vector or N-terminally truncated Notch1 (mutant A) were ®rst generated and were subsequently infected with a retrovirus expressing the activated neu/erbB2 oncogene. No signi®cant dierence could be observed as compared to controls in the number of size of foci generated when the two genes were expressed together (data not shown).
It has been shown recently that activated Notch1 intra can activate the c-neu/erbB2 gene promoter (Chen et al., 1997) . To determine whether this was occurring in our system and could explain the transformed phenotype, we have studied the expression of the cneu/erbB2 gene in clones of HC11 cells infected with truncated Notch1 (mutant A). By Northern blot analysis, we did not observe overexpression of c-neu/ erbB2 in these clones, as compared to control HC11 cells expressing vector alone (data not shown), indicating that the eect of Notch1 in these cells in vitro was not mediated by enhanced levels of c-neu/ erbB2.
Growth of Notch1 transformed HC11 cells in nude mice
To determine whether the Notch1 intra -expressing HC11 cells growing in soft agar had acquired a malignant phenotype, cells from control and from four clones (32H, 25, 26 and 27) ( Figure 4f ) were assayed for growth in nude mice. Subcutaneous and intraperitoneal inoculations of these cells (1610 6 ) into nude mice did not lead to the development of subcutaneous tumors and lung and liver metastases after 4 ± 6 weeks, except with the 32H clone. These results indicated that HC11 cells overexpressing truncated-Notch1 intra were not able to induce the malignant transformation of HC11 cells even if these cells were able to form colonies in soft agar. It seems likely that some additional genetic events occurred in the 32H clone leading to its complete malignant transformation.
Analysis of the transforming potential of Notch1 intracytoplasmic mutants
To map the critical domain(s) of the intracellular portion of Notch1 required for transformation of HC11 cells, a deletion mutational analysis was carried out. Additional sequences were deleted from the transforming Notch1 mutant A used in the in vitro transformation assay ( Figure 5 ). Each of these mutants were also tagged at their C-terminus with the HA sequences. Mutants were cloned into the pBabe retrovirus vector.
The puromycin-resistant HC11 cells infected with each of the mutant retrovirus were ®rst observed for morphological changes. Cells infected with mutant B (DCys) and mutant E (DOPA) retroviruses appeared morphologically transformed (data not shown) as those infected with mutant A retrovirus (Figure 4 ). The same cells were then assayed for their ability to form colonies in soft agar. Growth in agar was observed Figure 5a ). Pools of puromycin-resistant cells were ®rst observed for morphological changes. The HC11 mammary epithelial cells infected with the control retrovirus alone formed ā at cuboidal and well-organized monolayer at con¯uence (a). Note that HC11 cells infected with mutant A construct had a transformed morphology with a ®broblastoid aspect and piling up of the cells on top of each others (b). The same cells were then seeded in 0.3% agar. Colonies which were growing in agar (clones 20, 21, 22, 24, 25, 26, 27 and 28) were picked, replated and analysed by Northern blotting with Notch1 probe K and retested for their growth in soft agar. Some puromycin-resistant cells were also cloned at random and tested in soft agar. Clone 32H was one of these clones which expressed the highest level of Notch1 transcript. (c, d and e) Soft agar colony formation assay. Control HC11 cells infected with the pBabe retrovirus vector alone (c); colonies of Notch1-infected HC11 cells (d and e). Colonies of dierent size were observed after 3 weeks. (f) Correlation between RNA expression of Notch1-mutant transcript in clones analysed by Northern blotting and the number of colonies after 3 weeks of growth in soft agar. Relative RNA expression was estimated by phosphorimager analysis as described in Materials and methods, and the highest value (32H) was normalized to 100. The average of the number of colonies obtained with each clone was plotted for cells infected with mutant A, mutant B (DCys) and mutant E (DOPA), but not with any of the other mutants ( Figure 5) .
Together, these results demonstrated that the extracellular region of Notch1 up to nt 5187 (aa 1704) and its intracellular C-terminal region, containing OPA and PEST domains, are dispensable for the transformation of HC11 cells. In addition, these results indicated that the 283 bp region (nt 5270 ± 5553, aa 1734 ± 1821) adjacent to the internal surface of the plasma membrane (domain I) and containing the CBF1/RBP-Jk primary binding site (Aster et al., 1997; Hsieh et al., 1996) and one nuclear localization signal (NLS) is critical for transformation. Our data showed that the ankyrin repeats are not sucient by themselves for transformation since mutant F (DTM) and G (M188) in which the six ankyrin repeats were intact could not induce growth in agar of HC11 cells. However, since no novel Notch1 protein could be detected by Western blotting in cells infected with mutant C (DAnk), the results obtained with this mutant cannot be compared directly with those obtained with the other mutants.
Expression analysis of Notch1 mutants in HC11 cells
The expression of Notch1 mutant constructs in pools of HC11 cells selected for their resistance to puromycin was ®rst determined by Northern blotting. Notch1-speci®c retroviral RNA of the expected size was detected at high levels in each infected pools (data not shown), indicating that transcription of the retroviral/Notch1 RNA was ecient, as expected.
The same pools of cells were then analysed for Notch1 protein expression by Western blotting using anti-Notch1 and anti-HA tag antibodies. Cells expressing truncated Notch1 intracytoplasmic mutant DNA have previously been reported to encode several Notch1 proteins of dierent length, partly due to the proteolytic processing of a TM-anchored species . Similarly, several novel Notch1-immunoreactive related proteins were detected in HC11 cells infected with each mutant, except with mutant C (DAnk) (Figure 6 ). HC11 cells infected with mutants A, D, E or F retrovirus each harbored three novel Notch1-related proteins, the shorter ones being most abundant, while cells infected with mutant B contained only two major novel Notch1-related proteins. With each of these mutants, the larger Notch1 protein was found to be of the expected size.
The apparent molecular weight of the Notch1 proteins encoded by the mutant A was *105, 100 and 85 kDa (Figure 6a (Figure 6a , lane 10). The fact that mutant A and mutant B (DCys) DNA encoded Notch1 proteins of apparent similar length (100 kDa) and gave a similar pattern of Notch1-related proteins, suggested that their RNAs might be translated similarly and that the methionine 1726 present in the TM domain was translated in mutant A more eciently than the upstream methionine 1660. Methionine 1726 is the ®rst methionine present in mutant B (DCys) and is likely the ®rst to be translated in this mutant. Methionine 1726 is also likely to be the major ®rst initiation codon in mutant D (DNLS), mutant E (DOPA) and mutant F (DTM) giving rise to proteins of 65, 55 and 90 kDa respectively. The longer Notch1 protein species encoded by mutants A and E (*105 and 58 kDa) could also be cleaved at a site downstream of the TM domain, between amino acid 1746 and 1756, as previously documented , to give rise to cleavage products of 100 and 55 kDa, respectively. This latter possibility of posttranslational cleavage is less likely for mutant D and F in which this cleavage site has been deleted. The levels of the larger Notch1 protein detected in HC11 cells infected with mutant A, D or F (*105, 68 and 95 kDa) were found to be low, while the ones in cells infected with mutant E (*58 kDa) were higher. This latter protein could possibly be more stable as a result of the loss of its PEST domain.
The second lower molecular weight Notch-related proteins encoded by the mutants A, B, E and F constructs (*85, 85, 40 and 85 kDa respectively) seemed to be initiated downstream, around methionine 1852, just before the ankyrin repeats. To mimic Notch1 and mammary epithelial cell transformation A Die Â vart et al the apparent structure of the 85 kDa protein encoded by mutants A, B and F, and of the 40 kDa protein encoded by mutant E, we generated an additional construct, mutant G (M188) with its ®rst potential initiating methionine at nt 1852, just before the ankyrin repeats. This DNA construct was found to code for a unique protein of 85 kDa which co-migrated with the smaller Notch1 proteins encoded by mutants A, B and F (Figure 6b ). In cells infected with mutant D, a similar second initiation site downstream of the deleted region in addition to the initiation at methionine 1726 may explain the presence of the shorter Notch1 protein species (*60 kDa).
The absence of detectable Notch1 proteins in cells infected with mutant C (DAnk) was unexpected. To rule out a defect of the construct, this mutant C DNA was assayed by transient transfection in 293T cells. By Western blotting, a protein of the expected size (*80 kDa) could be detected (data not shown), indicating that this DNA had an intact coding capacity.
Together, these results showed that approximately equal amount proteins were detected in pools of HC11 cells infected with each mutant, except mutant C (DAnk). Therefore, the lack of speci®c phenotypes seen with some mutants is unlikely to result from low levels of proteins, but rather from the mutation itself. Conversely, the transforming phenotype of mutant A, B and E is likely to be induced by the presence of these novel Notch1 protein species.
Discussion
Involvement of Notch1 in mammary tumor development
Our results show that Notch1 can be targeted by MMTV provirus in mammary tumors from MMTV/ neu Tg mice. Although such insertional mutations of Notch1 were found in a low percentage of the tumors analysed, these mutations are likely to participate in tumor formation, as they represent a highly selected genetic event considering the random integration of retroviral DNA. Very similar truncated Notch1 mutations have been observed in other tumors. Such mutations were ®rst reported in a few cases of human T-cell leukemia harboring the t(7 : 9) (q34;q34.3) chromosome translocation involving the T-cell receptor gene and the human homologue of Notch1, TAN-1 (Ellisen et al., 1991) . Recently, we found similar Notch1 provirus insertional mutations in a high proportion of the T-cell lymphomas induced in Moloney MuLVinfected MMTV D /myc Tg mice, suggesting a collaboration between Notch1 and c-myc (Girard et al., 1996) . In addition, a Notch1-related gene, Notch4/int3, has been reported to be truncated and activated by MMTV provirus insertions in mouse mammary tumors (Gallahan and Callahan, 1997) . The insertional mutations generated in these dierent tumors are very similar, and have all been selected for truncation upstream of the TM domain, suggesting that these truncated Notch intra mutants have the structure optimal for transformation.
Our present data extend these previous results and indicate that Notch1 can also be involved in the development of mouse mammary tumors, possibly in collaboration with the activated neu/erbB2 oncogene present as a transgene in these mice. Although we have been unable to document such a collaboration in cell lines in vitro, in vivo experiments involving the generation of double transgenic mice each expressing the activated neu/erbB2 and Notch1 intra oncogenes in mammary glands may reveal such a collaboration.
The spontaneously arising MMTV provirus insertional mutations of Notch1 in the mammary tumors described here led to the disruption of the gene and to a complex expression phenotype. First, overexpression of novel truncated 7 kb RNAs, starting at the Notch1 promoter and arresting at the site of provirus integration, was detected. These truncated 5' RNAs have the capacity to code for a mutant protein harboring only the Notch1 ectodomain, N(EC) Mut , of an expected molecular weight of *275 kDa. We indeed recently found that the normally processed Notch1 ectodomain, N(EC) WT , and the N(EC) Mut often co-migrate, have virtually the same structure, are both released from the cells as soluble forms, but are located in dierent cell compartments (Hoemann et al., 1999) . Therefore, the *280 kDa Notch1 protein found to be present at high levels in the two mammary tumors with Notch1 rearrangement are likely to represent a mixture of N(EC) WT (Sun and ArtavanisTsakonas, 1997) . Since Notch1 and its ligands share the same general structure, it is tempting to hypothesize that N(EC) Mut may work similarly and antagonize Notch1-ligand signaling and thus in¯uence tumor formation. Further work will be needed to test this hypothesis.
Another important consequence of the MMTV provirus integration event is the expression of novel truncated 3' Notch1 RNAs. These truncated 3.5 and/or 4.5 kb RNAs in tumors T24c and T1571-63 are likely to be initiated from the MMTV LTR and from a cryptic promoter, respectively. This hypothesis of a cryptic promoter is supported by a previous analysis made in our laboratory on T-cell lymphomas induced in Moloney MuLV-infected MMTV D /myc Tg mice, and harboring a MuLV provirus inserted in the Notch1 gene at the same location as the MMTV provirus in tumor T1571-63 (Girard et al., 1996) . The MMTV LTR inserted in the antisense orientation with respect to the Notch1 gene in tumor T1571-63 may provide enhancer functions. These truncated RNAs are likely to code for novel truncated proteins (95 and/or 100 kDa) detected in these tumors. We and others have previously shown that the other truncated proteins (86 ± 110 kDa) could be derived from the processing of the 330 kDa precursor protein (Girard et al., 1996; Aster et al., 1994) . Moreover, some of these truncated proteins have been reported to be derived from further processing of the truncated proteins themselves .
The Notch1 expression phenotype observed here in mammary tumors is virtually identical to the one we observed in T-cell tumors harboring MuLV provirus insertional mutations of Notch1 in MMTV D /myc Tg mice (Hoemann et al., 1999; Girard et al., 1996) , Notch1 and mammary epithelial cell transformation A Die Â vart et al strongly suggesting speci®c structural requirements and similar mechanisms in both types of tumors.
Structural requirement of the intracytoplasmic Notch1 protein for its transforming activity
We have developed an in vitro transformation assay for intracytoplasmic Notch1 in mouse HC11 mammary cells. We ®rst assayed a 3' truncated Notch1 intra cDNA designed to mimic the structure of the mutant truncated intracytoplasmic Notch1 RNA generated by the provirus insertional mutation. In this in vitro assay, this 3' truncated Notch1 intra construct had transforming potential, thus indicating that it behaves as an oncogene. A similar but not identical 3' truncated Notch1 construct has been shown to have transforming activity for T-cells in bone marrow cells transplanted in vivo (Pear et al., 1996; Aster et al., 1994) . Capobianco et al. (1997) have also recently reported that a similar 3' truncated Notch1 cDNA could transform Baby rat kidney (BRK) cells in vitro, but only in the presence of the E1A viral oncogene (Capobianco et al., 1997) . The transformation assay we have developed for the 3' truncated Notch1 intra in HC11 cells oers the advantage of being in vitro and not requiring a second cooperating oncogene. It is likely that HC11 cells express speci®c eector(s) required for Notch1 transformation since other cells such as Rat1 (our unpublished observations) or BRK (Capobianco et al., 1997) cells could not be transformed by the truncated Notch1 intra cDNA used. Interestingly, HC11 cells can also be transformed by the 3' truncated Notch4/int-3 gene (Robbins et al., 1992) .
The availability of the HC11 mammary epithelial cell in vitro transformation assay has allowed us to analyse some intracytoplasmic Notch1 mutants for transforming activity and to de®ne the sequences of the Notch1 protein which appear to be required or dispensable for this activity. We found that transformation of HC11 cells by truncated Notch1 proteins requires the ankyrin repeats and a domain (domain I, amino acids 1751 ± 1821) located N-terminal to the ankyrin repeats and containing the RBP-Jk/CBF1 primary binding site and the NLS1. The OPA and PEST regions, the two conserved cysteines (C 1652 and C 1685 ) and the signal peptide were dispensable for this activity.
Several Notch1 mutants have been studied in vertebrates in dierent assays scoring for inhibition of either myogenic (Shawber et al., 1996; Nye et al., 1994; Kopan et al., 1994 Kopan et al., , 1996 , neurogenic , granulocytic (Milner et al., 1996) or lymphoblastic (Washburn et al., 1997; Robey et al., 1996) dierentiation and for leukemia after transplantation of bone marrow cells in vivo (Pear et al., 1996; Aster et al., 1994) . Comparison of these studies with our results is informative. In contrast to the Notch1 mutants studied here, several mutants previously reported had a N-terminal signal peptide (Lu and Lux, 1996; Pear et al., 1996; Aster et al., 1994; Kopan et al., 1996) . We did not add such a signal peptide in our constructs to mimic as closely as possible the mutations spontaneously arising by provirus insertion. Despite this dierence, our data con®rm that the presence or the absence of the two conserved cysteines at the Nterminal of the mutant construct (C 1652 and C
1685
) had no in¯uence on the transforming ability (Pear et al., 1996) . The ankyrin-repeats region is known to bind with some eectors of Notch (Diederich et al., 1994; Jarriault et al., 1995; Guan et al., 1996; Aster et al., 1997; Fortini and Artavanis-Tsakonas, 1994) . In most biological assays, the presence of this region has been found to be required to elicit a phenotype Wettstein et al., 1997; Milner et al., 1996) , although Notch1 mutants deleted of ankyrin-repeats have been reported to exhibit signi®cant residual activity in some functional assays Aster et al., 1997) . Our data also suggest that the ankyrin-repeats are necessary, but not sucient, for transformation of HC11 cells.
Regarding the C-terminal part of the protein, Lu and Lux have reported that the OPA sequences were required for the complete activation by truncated Notch1 of a CBF1-responsive reporter construct in Cos-1 cells (Lu and Lux, 1996) . This contrasts with our ®ndings that these sequences are dispensable for transformation of HC11 cells and that their deletion seems to stabilize the protein and to increase the phenotype. Similarly, most other studies reported that these OPA/PEST sequences are dispensable to elicit several other gain-of-function phenotypes (Wettstein et al., 1997; Robey et al., 1996; Milner et al., 1996; Kopan et al., 1994 Kopan et al., , 1996 Hsieh et al., 1996) .
The domain I (aa 1751 ± 1821) between the TM and ankyrin-repeat regions has been found to be the primary site of binding of the RBPJ-k/CBF1 transcription factor Tamura et al., 1995) and to be required for some biological functions of Notch1 (Wettstein et al., 1997; Hsieh et al., 1996; Jarriault et al., 1995) . However, Notch1 mutants deleted of these sequences have also been reported to have functional activity, indicating the presence of CBF1-independent pathways (Shawber et al., 1996; Aster et al., 1997; Kopan et al., 1994) . In contrast, transformation of HC11 cells by Notch1 intra appears to require domain I, since mutant G and mutant F, deleted of most of this domain, were inactive. This result suggests that the HC11 transformation event may be CBF1-dependent. Together, these data suggest that intracytoplasmic Notch1 interacts with dierent eectors in dierent cell types.
The novel biological assay described here and scoring for in vitro transformation of mammary epithelial cells is likely to be instrumental in studying the downstream eectors of Notch1 intra and the Notch1 intra domains involved in the transformation pathways, particularly the transformation of mammary epithelial cells.
Materials and methods
Mice and MMTV infection
Newborn MMTV/neu Tg mice (Bouchard et al., 1989) were foster-nursed to C3H/OuJ (Jackson Laboratory, Bar Harbor) lactating mice producing infectious MMTV in their milk. The MMTV-infected MMTV/neu Tg females were observed for spontaneous tumor development and the mammary tumors were collected. Nude mice were from Harlan Sprague Dawley Inc. (Indianapolis, USA).
